Showing results (751-760 of 3,492) with videos related to
Sort By:
Pageof 350
Archiv Der Pharmazie|November 13, 2024
Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin-topoisomerase II inhibitorsÁngela-Patricia Hernández, Celia Rosales-Fernández, Carolina Miranda-Vera, et al.Archiv Der Pharmazie|November 16, 2024
Synthesis of hydroxytyrosol analogs with enhanced antioxidant and cytostatic properties against MG-63 human osteoblast-like cells and their potential implications for bone healthEleftheria A Georgiou, Ioanna Kalpaktsi, Katerina Gioti, et al.Archiv Der Pharmazie|November 28, 2024
Identification of potentially causative drugs associated with hypotension: A scoping reviewNurunnisa Sari, Ulrich Jaehde, Anna Maria WermundArchiv Der Pharmazie|March 17, 2025
Xylazine as an emerging new psychoactive substance; focuses on both 5-HT7 and κ-opioid receptors' molecular interactions and isosteric replacementGiuseppe Floresta, Alberto Granzotto, Vincenzo Patamia, et al.Archiv Der Pharmazie|October 5, 2024
Insight into the therapeutic potential of pyrazole-thiazole hybrids: A comprehensive reviewGarima Sumran, Manisha Sharma, Ranjana AggarwalArchiv Der Pharmazie|October 9, 2024
Pentathiepins are an understudied molecular prism of biological activitiesLuca Pozzetti, Christopher R M AsquithArchiv Der Pharmazie|August 5, 2024
Synthesis, in vitro anticancer activity, and pharmacokinetic profiling of the new tetrahydropyrimidines: Part IEmilija Milović, Jovana Trifunović Ristovski, Srđan Stefanović, et al.Archiv Der Pharmazie|August 1, 2024
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease managementDalia H Abu-Baih, Fatma Mohamed Abd El-Mordy, Entesar Ali Saber, et al.Archiv Der Pharmazie|August 6, 2024
Novel tetrahydropyran-triazole hybrids with antiproliferative activity against human tumor cellsVanesa Quintana, Aday González-Bakker, Adam N Khan, et al.Archiv Der Pharmazie|July 15, 2024
Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylasesJohannes Seitz, Marina Auth, Tony Prinz, et al.Pageof 350